FDA Says No to Weight-Loss Combo Drug - QualityPoint Technologies
Links shared publicly online about this topic.
- 538total visits
FDA Says No to Weight-Loss Combo Drug - QualityPoint Technologies
View full resource at qualitypointtech.net
Tags: Obesity Medication, Antidepressant, Drug, Smoking Cessation Medication, FDA, Wellbutrin, Zyban
Most Recently Shared on February 1, 2011 at 6:01 pm By:
FDA Says No to Weight-Loss Combo Drug: (MedPage Today) -- A pill combining bupropion and naltrexone for weight los... http://bit.ly/eKfeef
FDA Says No to Weight-Loss Combo Drug Contrave - ABC News
abcnews.go.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risks, the company said.” View full resource at abcnews.go.com
Most Recently Shared on February 5, 2011 at 1:27 pm By:
FDA Says No to Weight-Loss Combo Drug http://bit.ly/gAs5L8
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:50 pm By:
FDA Says No to Weight-Loss Combo Drug http://bit.ly/hL8N7y
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:39 pm By:
Evelyn Tribole Nutritionist, Dietitian, and Active Health Library
FDA Says No to Weight-Loss Combo Drug, Contrave, which consists of bupropion and naltrexone. http://bit.ly/g6SOkp
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:13 pm By:
FDA says no to weight-loss combo drug: http://bit.ly/eTFDFC
Advertisement
